Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Syracuse Radiation Oncology deploys RapidArc radiotherapy on first patients

Varian : 03 October, 2008  (Application Story)
RapidArc radiotherapy technology from Varian Medical Systems has been deployed by doctors Syracuse Radiation Oncology in Syracuse, New York, USA for the first time.
RapidArc delivers a precise image-guided IMRT treatment in two minutes or less, which is two to eight times faster than was previously possible with conventional IMRT.

A 70-year-old prostate cancer patient was the first person to begin a course of RapidArc treatments at Syracuse Radiation Oncology, an early adopter and the one of the first sites in upstate New York to offer this form of treatment. Each of his daily treatments is taking just under two minutes to deliver.

'Compared with a traditional IMRT approach, we're finding that a RapidArc treatment is noticeably faster to deliver,' said Neil Mariados, MD, radiation oncologist, Syracuse Radiation Oncology. 'A shorter treatment time means that patients spend less time holding still, and we believe this has the potential to improve treatment accuracy as the targeted tumour is less likely to shift position during a shorter treatment. Because RapidArc provides the accuracy we demand in a patient's radiotherapy, but in a shorter time frame, we are able to provide exceptional care to each of them.'

RapidArc makes it possible to cover the tumour with radiation during a single continuous rotation of the treatment machine around the patient. This makes it much faster than conventional IMRT, which repositioned the machine repeatedly for treating from different angles.

'RapidArc was able to meet the challenge of concentrating the dose on the patient's tumour, and minimising any exposure of nearby healthy organs,' Mariados said.

Treatment planning analyses conducted by Varian and clinical researchers have shown that in many cases, RapidArc concentrates dose more closely on the tumor than conventional fixed beam IMRT treatments. Additionally, studies show that faster treatments can help to minimise the effects of prostate motion during treatment, and potentially lead to a higher cancer cell kill rate.

RapidArc Radiotherapy technology has now been used for the treatment of prostate, head and neck, lung, brain, spine, bone, gynaecological, and soft tissue cancers.
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo